Attachment

not support this legislation, we remain 5 PM [AID DEA DART ID DIR-OCGR < I I (ID DCR-OCGR ay ' TT IIAID) (NIH/NIAID) [E] P| [E] 4/NIAID) [E] I I VIH/NIAID) [I] iy >; P| (NIH/NIAID) [E] P| IIH/NIAID) [--] NIAID) [E] 'nate Committee on S is now requesting any y (9/27), ct 7PM [AID DEA DART NIAID) [E] i NIAID) [E] VIH/NIAID) [E] ii st NIH/NIAID) [E] VIH/NIAID) [E] iy >; al || (NIH/NIAID) [E] NIH/NIAID) [E] ay NIAID) [E] on public health, safety, and national security. We recommend that enforcement provisions be focused on willful violations and significantly reduced or adjusted. Given the above concerns, as drafted, this legislation has the potential to negatively impact innovation and delay the development of lifesaving technologies. While the Administration does not support this legislation, we remain committed to working with the Committee on biosafety and biosecurity.